← Leaderboards
Mohamed A. Zayed
Washington University
$7,854,663
Attributed
$14,492,604
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,492,604 · 8
By mechanism
R01$10,912,575 · 4
R42$1,950,568 · 1
T32$969,532 · 1
K08$465,828 · 1
R41$194,101 · 1
Top collaborators
- Pamela K Woodard9 shared
- Robert J Gropler8 shared
- Guy M Genin2 shared
- Eric Claude Leuthardt2 shared
- Stacey Liekweg2 shared
Most similar at Washington University
Same institution · by research overlap
- Suresh Vedantham$19,226,475
- John F Dipersio$33,235,840
- Marc R Moon$2,323,688
- Reece Joseph Goiffon$86,081
- Colin Pieter Derdeyn$10,282,174
Others in their field
Other Emerging Leaders on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Craig Reist · Research Triangle Institute$22,725,934
- Lisa Newman · Research Triangle Institute$22,725,934
Research focus
Operative Surgical ProceduresTissuesCellsMolecularMediatingGene ExpressionBlood VesselsBasePeripheral Arterial DiseasePeripheralSignal TransductionAtherosclerosisDisease ProgressionDiabetes MellitusMacrophageInflammationPlayRadiotracerAmericanImageDetectionEndotheliumPositron-Emission TomographyMorbidity - Disease Rate
Grant awards (26)
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis$664,123
R01 · FY2025 · HL
Cardiovascular Innovation Program in Surgery & Engineering$650,830
T32 · FY2025 · HL · contact PI
PET Detection of CCR2 in Human Atherosclerosis$715,437
R01 · FY2024 · HL
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis$668,436
R01 · FY2024 · HL
Regulation of Endothelial Lipid Metabolism in the Setting of Diabetes and Critical Limb Ischemia to Prevent Surgical Complications$514,989
R01 · FY2024 · HL · contact PI
Cardiovascular Innovation Program in Surgery & Engineering$318,702
T32 · FY2024 · HL · contact PI
PET Detection of CCR2 in Human Atherosclerosis$748,898
R01 · FY2023 · HL
CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms$742,679
R01 · FY2023 · HL · contact PI
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis$702,914
R01 · FY2023 · HL
Regulation of Endothelial Lipid Metabolism in the Setting of Diabetes and Critical Limb Ischemia to Prevent Surgical Complications$525,499
R01 · FY2023 · HL · contact PI
Isovolumetric Multimodal Venous Thrombectomy System$969,525
R42 · FY2022 · HL
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis$766,394
R01 · FY2022 · HL
CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms$753,767
R01 · FY2022 · HL · contact PI
PET Detection of CCR2 in Human Atherosclerosis$748,903
R01 · FY2022 · HL
Regulation of Endothelial Lipid Metabolism in the Setting of Diabetes and Critical Limb Ischemia to Prevent Surgical Complications$525,499
R01 · FY2022 · HL · contact PI
Isovolumetric Multimodal Venous Thrombectomy System$981,043
R42 · FY2021 · HL
CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms$764,792
R01 · FY2021 · HL · contact PI
PET Detection of CCR2 in Human Atherosclerosis$748,903
R01 · FY2021 · HL
Regulation of Endothelial Lipid Metabolism in the Setting of Diabetes and Critical Limb Ischemia to Prevent Surgical Complications$556,358
R01 · FY2021 · HL · contact PI
THE ROLE OF PHOSPHOLIPOGENESIS IN DIABETIC PERIPHERAL ARTERIAL DISEASE$92,646
K08 · FY2021 · HL · contact PI
PET Detection of CCR2 in Human Atherosclerosis$764,984
R01 · FY2020 · HL
Multi-Modal Venus Clot Removal Device$194,101
R41 · FY2020 · HL · contact PI
THE ROLE OF PHOSPHOLIPOGENESIS IN DIABETIC PERIPHERAL ARTERIAL DISEASE$92,919
K08 · FY2020 · HL · contact PI
THE ROLE OF PHOSPHOLIPOGENESIS IN DIABETIC PERIPHERAL ARTERIAL DISEASE$93,179
K08 · FY2019 · HL · contact PI
THE ROLE OF PHOSPHOLIPOGENESIS IN DIABETIC PERIPHERAL ARTERIAL DISEASE$93,425
K08 · FY2018 · HL · contact PI
THE ROLE OF PHOSPHOLIPOGENESIS IN DIABETIC PERIPHERAL ARTERIAL DISEASE$93,659
K08 · FY2017 · HL · contact PI